Evidence of the Regulatory Effect of Ginkgo biloba Extract on Skin Blood Flow and Study of its Effects on Urinary Metabolites in Healthy humans

Abstract

Ginkgo biloba extract has been advocated for the improvement of blood circulation in circulatory disorders. This study investigated the effect of the Gingko biloba extract EGb 761 on skin blood flow in healthy volunteers and accompanying changes in urinary metabolites. Twenty-seven healthy middle-aged subjects participated in a randomized, double-blind, placebo-controlled, crossover study. Subjects received 240 mg/d EGb 761 or placebo for periods of 3 weeks. Skin blood flow was measured on the forefoot using laser Doppler flowmetry and changes in urinary metabolites were identified by a combination of nuclear magnetic resonance (NMR) spectroscopy and multivariate data analysis (MVDA). These measurements were performed on 24-h urine samples collected at the end of the intervention periods. Following EGb 761 treatment, overall mean skin blood flow was significantly reduced as compared with placebo. Remarkably, the change of skin blood flow after EGb 761 intervention was proportionally related to blood flow after placebo treatment: subjects showed either an increased, decreased or unaltered skin blood flow. NMR/MDVA analyses showed that urinary metabolic patterns differed depending on the change in baseline blood flow after treatment with EGb 761. The present findings substantiate that EGb 761 has a multi-directional modulating action on blood flow in healthy subjects and support findings of a vasoregulatory role of this extract. Moreover, the results indicate that metabolic fingerprinting provides a powerful means to identify biochemical markers that are associated with functional changes.

Abbreviations

MDVA:multivariate data analysis

N-PLS:partial least squares

NMR:nuclear magnetic resonance

pu:perfusion units

Circulation disorders - Ginkgo biloba extract - Ginkgoaceae - metabolic fingerprinting - NMR spectroscopy

References

• 1 Diamond B J, Shiflett S C, Feiwel N, Matheis R J, Noskin O, Richards J A. et al . Ginkgo biloba extract: mechanisms and clinical indications.  Arch Phys Med Rehabil. 2000;  81 668-77
• 2 Christen Y. From clinical observations to molecular biology: Ginkgo biloba extract EGB 761, a success for reverse pharmacology.  Curr Top Nutraceutical Res. 2003;  1 59-72
• 3 Pittler M H, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.  Am J Med. 2000;  108 276-81
• 4 Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers.  Arzneimittelforsch. 1990;  40 589-93
• 5 Witte S, Anadere I, Walitza E. Verbesserung der Hämorheologie durch Ginkgo-biloba-Extrakt. Verminderung eines kardiovaskularen Risikofaktors.  Fortschr Med. 1992;  13 247-50
• 6 McKenna D J, Jones K, Hughes K. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications.  Altern Ther Health Med. 2001;  7 70-90
• 7 Mehlsen J, Drabaek H, Wiinberg N, Winther K. Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers.  Clin Physiol Funct Imagin. 2002;  22 375-8
• 8 Lindon J C, Nicholson J K, Holmes E, Everett J R. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids.  Concepts Magn Reso. 2002;  12 289-320
• 9 Lamers R -J, DeGroot J, Spies-Faber E J, Jellema R H, Kraus V B, Verzijl N. et al . Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic guinea pigs.  J Nutr. 2003;  133 1776-80
• 10 Nilsson G E, Tenland T, Oberg P A. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow.  IEEE Trans Biomed Eng. 1980;  27 597-604
• 11 Auguet M, Delaflotte S, Hellegouarch A, Clostre F. Pharmacological bases of the vascular impact of Ginkgo biloba extract.  Presse Med. 1986;  15 1524-8
• 12 Auguet M, DeFeudis F V, Clostre F, Deghenghi R. Effects of an extract of Ginkgo biloba on rabbit isolated aorta.  Gen Pharmacol. 1982;  13 225-30
• 13 Logani S, Chen M C, Tran T, Le T, Raffa R B. Actions of Ginkgo biloba related to potential utility for the treatment of conditions involving cerebral hypoxia.  Life Sci. 2000;  67 389-96
• 14 Damas J, Garbacki N, Liegeois J F, Juchmes J. Control of cutaneous blood vessels.  Rev Med Liege. 2001;  56 846-9
• 15 Wu G, Morris S M. Arginine metabolsim: nitric oxide and beyond.  Biochem J. 1998;  336 1-17
• 16 Pietri S, Maurelli E, Drieu K, Culcasi M. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761).  J Mol Cell Cardiol. 1997;  29 733-42
• 17 Johns L, Sinclair A J, Davies J A. Effects of bilobalide on hypoxia/hypoglycemia-stimulated glutamate efflux from rat cortical brain slices.  Neurochem Res. 2002;  27 369-71
• 18 Kleijnen J, Knipschild P. Ginkgo biloba.  Lancet. 1992;  340 1136-9
• 19 Nishida S, Satoh H. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.  Life Sci. 2003;  72 2659-67
• 20 Kubota Y, Tanaka N, Umegaki K, Takenaka H, Mizuno H, Nakamura K. et al . Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level.  Life Sci. 2001;  69 2327-36
• 21 Christen Y, Maixent J M. What is Ginkgo biloba extract EGb 761? An overview - from molecular biology to clinical medicine.  Cell Mol Biol. 2002;  48 601-11